QVT Financial »

Tourmaline Bio shares owned by QVT Financial

Quarter-by-quarter ownership of Tourmaline Bio (TRML) shares owned by QVT Financial from 13F filings

Historical chart of QVT Financial investment in Tourmaline Bio

Tip: Access up to 7 years of quarterly data

All positions including Tourmaline Bio held by QVT Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tourmaline Bio by QVT Financial

Quarter filed Position value Share count Share price at filing
2023-12-31 $25M 948k 26.18

More positions owned by QVT Financial

Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Mp Materials Corp Com Cl A (MP)
ImmunoGen
Goldman Sachs (GS)
Nexstar Media Group Common Stock (NXST)
Carnival Corp Unit 99/99/9999 Call Option (CCL)
Tourmaline Bio (TRML)
Nelnet Cl A (NNI)
Makemytrip Limited Mauritius SHS (MMYT)
Nio Note 4.500% 2/0 (Principal)
Sea Note 2.375%12/0 (Principal)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Anterix Inc. Atex (ATEX)
New York Times Cl A (NYT)

View all positions for QVT Financial

Top funds holding Tourmaline Bio

Blue Owl Capital Holdings
Jennison Associates
QVT Financial
Braidwell
venBio Select Advisor
Vanguard Group
Dr. Jeffrey R. Jay, M.D.
Qiming U.S. Ventures Management
Vivo Capital
Nantahala Capital Management
Balyasny Asset Management
Logos Global Management
Artal Group
AlphaCentric Advisors
Two Sigma Investments

View all funds holding Tourmaline Bio